FEB 2018

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/932603

Contents of this Issue


Page 150 of 150

The CATALYS ® System TAKE THE FAST TRACK TO SURGICAL EXCELLENCE JUST GO OptiMedica and CATALYS are trademarks owned by or licensed to Abbott Medical Optics Inc., its subsidiaries or affiliates. ©2018 Abbott Medical Optics Inc. | www.CatalysLaser.com | PP2017CT2142 Yb Laser: Laser Class 4/IV Max Output: 1030nm, 10uJ, 1.8W, <900fs Pulse SLD Laser: Laser Class 3R Max Output: 820-930nm, <3.48mW, CW Per IEC 60825-1:2007 INVISIBLE LASER RADIATION AVOID EYE OR SKIN EXPOSURE TO DIRECT OR SCATTERED RADIATION CLASS 4 LASER PRODUCT INDICATIONS AND IMPORTANT SAFETY INFORMATION FOR THE CATALYS ® PRECISION LASER SYSTEM Rx Only INDICATIONS: The OptiMedica ® CATALYS ® Precision Laser System is indicated for use in patients undergoing cataract surgery for removal of the crystalline lens. Intended uses in cataract surgery include anterior capsulotomy, phacofragmentation, and the creation of single-plane and multi-plane arc cuts/incisions in the cornea, each of which may be performed either individually or consecutively during the same procedure. CONTRAINDICATIONS: Should not be used in patients with corneal ring and/or inlay implants, severe corneal opacities, corneal abnormalities, significant corneal edema or diminished aqueous clarity that obscures OCT imaging of the anterior lens capsule, patients younger than 22 years of age, descemetocele with impending corneal rupture, and any contraindications to cataract surgery. IMPORTANT SAFETY INFORMATION: Mild petechiae and subconjunctival hemorrhage can occur due to vacuum pressure of the suction ring. Potential complications and adverse events include any of those generally associated with cataract surgery. CAUTION: Should be used only by qualified physicians who have extensive knowledge of the use of this device and have been trained and certified by Abbott Medical Optics/OptiMedica. ATTENTION: Reference the labeling for a complete listing of Important Indications and Safety Information. M A KE YO U R M OV E AT A S C R S B O OT H #1817

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - FEB 2018